Amanda DiGuilio, PhD

As a consultant, Amanda has focused on the therapeutic areas of oncology and rare neurological diseases. She has experience in the evolution of medical devices and development of specialty pharmacy drug programs. Amanda’s extensive analytical experience has been applied to secondary and primary research. Her previous work includes competitive assessments, development of treatment landscapes, as well as pipeline and clinical development analyses. Prior to consulting, Amanda worked as a postdoc at the University of Chicago where she developed a CRISPR pipeline for human cell culture systems. Her PhD research in cell and structural biology was performed at EMBL in Heidelberg, Germany. Amanda has earned a BS/MS in Chemistry at Stevens Institute of Technology in Hoboken NJ.